Preliminary evidence of behavioral predictors of recurrent drug-induced psychosis in methamphetamine abuse

Psychiatry Research

Volumn 157, Issue 1-3, 2008, Pages 273-277

  Salo, Ruth ^a,b   Nordahl, Thomas E ^a,b   Leamon, Martin H ^a   Natsuaki, Yutaka ^b,d   Moore, Charles D ^c   Waters, Christy ^c   Carter, Cameron S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

^d University of California   (United States)

Author keywords

Attention; Prefrontal cortex; Psychosis; Substance abuse

Indexed keywords

METHAMPHETAMINE;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SUBSTANCE ABUSE;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; PREFRONTAL CORTEX; PSYCHOMOTOR AGITATION; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 36448966769     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2007.04.018     Document Type: Article

References (18)

1. Broome M.R., Woolley J.B., Tabraham P., Johns L.C., Bramon E., Murray G.K., Pariante C., McGuire P.K., and Murray R.M. What causes the onset of psychosis?. Schizophrenia Research 79 1 (2005) 23-34
2. Buss A.H., and Durkee A. An inventory for assessing different kinds of hostility. Journal of Counseling Psychology 21 (1957) 343-349
3. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., and Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction. Biological Psychiatry 57 10 (2005) 1117-1127
4. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh E.W., Hsiao C.C., Chiang Y.L., Ree S.C., Lee C.H., and Murray R.M. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine 33 8 (2003) 1407-1414
5. Chen C.K., Lin S.K., Sham P.C., Ball D., Loh el W., and Murray R.M. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics, Part B Neuropsychiatric Genetics 136 1 (2005) 87-91
6. Clure C., Brady K.T., Saladin M.E., Johnson D., Waid R., and Rittenbury M. Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse 25 3 (1999) 441-448
7. Gelernter J., Kranzler H.R., Satel S.L., and Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11 3 (1994) 195-200
8. Keshavan M.S., Sujata M., Mehra A., Montrose D.M., and Sweeney J.A. Psychosis proneness and ADHD in young relatives of schizophrenia patients. Schizophrenia Research 59 1 (2003) 85-92
9. Lynskey M.T., and Hall W. Attention deficit hyperactivity disorder and substance use disorders: is there a causal link?. Addiction 96 6 (2001) 815-822
10. Matsumoto T., Kamijo A., Yamaguchi A., Iseki E., and Hirayasu Y. Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report. Psychiatry and Clinical Neurosciences 59 1 (2005) 102-105
11. Matsumoto T., Yamaguchi A., Asami T., Kamijo A., Iseki E., Hirayasu Y., and Wada K. Drug preferences in illicit drug abusers with a childhood tendency of attention deficit/hyperactivity disorder: a study using the Wender Utah Rating Scale in a Japanese prison. Psychiatry and Clinical Neurosciences 59 3 (2005) 311-318
12. Nelson H.E. The National Adult Reading Test (NART) (1982), Nelson Publishing Company, Windsor, Canada
13. United Nations Office on Drugs and Crime. The world drug problem: A status report. World Drug Report vol. 1 (2004), United Nations, Vienna
14. Roehr B. Half a million Americans use methamphetamine every week. BMJ. British Medical Journal (Clinical Research Edition) 331 7515 (2005) 476
15. Suzuki A., Nakamura K., Sekine Y., Minabe Y., Takei N., Suzuki K., Iwata Y., Kawai M., Takebayashi K., Matsuzaki H., Iyo M., Ozaki N., Inada T., Iwata N., Harano M., Komiyama T., Yamada M., Sora I., Ujike H., and Mori N. An association study between catechol-O-methyl transferase gene polymorphism and methamphetamine psychotic disorder. Psychiatric Genetics 16 4 (2006) 133-138
16. Ward M.F., Wender P.H., and Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 150 6 (1993) 885-890
17. Wender P. (Adult-Questionnaire-Childhood Characteristics) scale. Psychopharmacology Bulletin 21 (1985) 927-928
18. Wood S.J., Pantelis C., Proffitt T., Phillips L.J., Stuart G.W., Buchanan J.A., Mahony K., Brewer W., Smith D.J., and McGorry P.D. Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine 33 7 (2003) 1239-1247